International Liver Congress™ 2022


22-26 June, 2022 London
N. Poster
Poster title
Applicant name
  FRI-001 Obeticholic acid exacerbates the liver fibrosis of bile duct ligation model by inducing the liver expression of osteopontin Jie Wang Received Received
  FRI-004 Two different types of COVID-19 vaccines and serial liver biochemistries Grace Wong Received Received
  FRI-005 Role of liver biopsy in management of immune checkpoint inhibitors hepatitis: a single-center retrospective study Lucia Parlati Received Received
  FRI-007 Liver toxicities of immune checkpoints inhibitors for cancer: a multicenter retrospective study Lucia Parlati Received Received
  THU-010 Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study Axel Wester Received Received
  SAT-011 NAFLD-induced encephalopathy is associated with low-grade brain tissue hypoxia and inflammation, as well as cerebrovascular, glial, metabolic and behavioural alterations Anna Hadjihambi Received Received
  THU-016 Patient and system-level factors underline offering and acceptance of alcohol use disorder therapy in veterans with cirrhosis Jasmohan S Bajaj Received Received
  THU-023 Active alcohol misuse is linked with lower short-chain fatty acid producing microbiota in a matched study of 450 patients with cirrhosis Jasmohan S Bajaj Received Received
  SAT-024 Isoleucine and valine correct hepatic lipid processing, reduce liver steatosis and suppress inflammation in obese mice with manifest NASH Eveline Gart Received Received
  SAT-025 Butyrate protects against diet-induced NASH and liver fibrosis and suppresses specific non-canonical TGFB signaling pathways in human hepatic stellate cells Eveline Gart Received Received
  FRI-026 Three COVID-19 medications - remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir - and serial liver biochemistries in 22,456 subjects Grace Wong Received Received
  THU-035 Prophylaxis of withdrawal syndrome decreases mortality in patients with alcohol-associated hepatitis David Marti-Aguado Received Received
  FRI-036 Impact of alcohol use on the diagnostic performance of serum-based indices for fatty liver disease Oscar Danielsson Received Received
  FRI-047 Radiowater perfusion PET of the liver, and its value as a biomarker to discriminate between NAFLD and NASH, and activity and fibrosis grade Olof Eriksson Received Received
  FRI-049 Association of the biological age and the level of global deoxyribonucleic acid methylation with metabolic parameters in patients with non-alcoholic fatty liver disease Anastasiia Radchenko Received Received
  THU-050 The prevalence of non-alcoholic fatty liver disease in the United Kingdom: a systematic review and meta-analysis Yusef Alenezi Received Received
  THU-051 Health-related quality of life is impaired in people living with HIV and hepatic steatosis Maurice Michel Received Received
  THU-053 Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: korean military population-based cross-sectional study Jaejun Lee Received Received
  FRI-053 The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD Magnus Holmer Received Received
  THU-055 Association of non-alcoholic fatty liver disease and fibrosis with incident dementia and cognitive function: the Rotterdam Study Laurens Van Kleef Received Received
  FRI-056 Ectopic fat deposition in the liver and pancreas and the presence of excess visceral adipose tissue significantly increase hospitalisation risk following COVID-19 Tom Waddell Received Received
  FRI-059 Knowledge of liver fibrosis stage among adults with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis improves adherence to life style changes Jeffrey Lazarus Received Received
  THU-060 The impact of liver fibrosis on the immune response to SARS-CoV-2 vaccination in metabolic associated fatty liver disease patients Marta Freitas Received Received
  FRI-061 Independent determinants of CAP values in healthy individuals with dysmetabolism Cristiana Bianco Received Received
  FRI-063 Correlations of 2D-Shear wave and transient elastography liver stiffness measurements in patients with non-alcoholic fatty liver disease Dimitrios Karagiannakis Received Received
  THU-064 Estimating the prevalence of advanced fibrosis due to nonalcoholic fatty liver disease in the United States population Naim Alkhouri Received Received
  SAT-065 MPEP, an mGlu5 receptor allosteric modulator, reduces hepatic steatosis in obese high-fat-diet mice Laura Giuseppina Di Pasqua Received Received
  THU-065 Non-alcholic fatty liver disease associated liver fibrosis is linked with the severity of coronnary artery disease mediated by systemic inflammation Xianbin Cai Received Received
  FRI-066 Incorporating a two-tiered liver fibrosis assessment into annual diabetes review in primary care - 3 year follow up study Dina Mansour Received Received
  FRI-073 High prevalence of multi-organ steatosis and fibroinflammation, identified by multi-parametric magnetic resonance imaging, in people with type 2 diabetes Nicole Eichert Received Received
  THU-077 Assessment of the prevalence of nonalcoholic fatty liver disease, its severity, and comorbidities in lean americans: national health and nutrition examination surveys (NHANES) with transient elastography assessment from 2017 to 2018 Emily Truong Received Received
  THU-084 The association between nonalcoholic fatty liver disease and insulin resistance within normal glucose level population chun-yi Wang Received Received
  THU-090 Nonalcoholic fatty liver disease impcat on cardiovascular disease death: a population-based study Chaonan Jin Received Received
  FRI-091 Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study David Marti-Aguado Received Received
  SAT-091 GL0034, A novel long-acting glucagon-like peptide 1 receptor agonist exhibits significant efficacy in aged db/db mouse model of non-alcoholic fatty liver disease (NAFLD) Rajamannar Thennati Received Received
  FRI-093 Aldafermin quantitatively improves inflammation in a 24-week clinical trial in patients with nonalcoholic steatohepatitis Tian Lan Received Received
  THU-100 Prevalence of non-alcoholic steatohepatitis in patients undergoing laparoscopic cholecystectomy for gallstone with non-alcoholic fatty liver disease Utpal Anand Received Received
  SAT-104 The effect of glucagon on rates of hepatic mitochondrial oxidation and pyruvate carboxylase flux in man assessed by positional isotopomer tracer analysis (PINTA) Kitt Petersen Received Received
  SAT-115 Oxygen-nutrient mismatch: a novel concept to explain how Obeticholic acid benefits NASH treatment Gerond Lake-Bakaar Received Received
  FRI-120 The Fibrosis-4 cut-off value for significant fibrosis is dependent on the type of non-alcoholic fatty liver disease patients Leen Heyens Received Received
  SAT-122 Efficacy and mechanism of time-restricted fasting in non-alcoholic liver disease Jiang Deng Received Received
  FRI-125 FIB-4 combined with positron emission tomography biomarkers detects fibrotic NASH Souvik Sarkar Received Received
  SAT-127 Spontaneous and drug-induced histological changes in nonalcoholic steatohepatitis: an assessment by meta-analysis of trials Grazia Pennisi Received Received
  SAT-137 Hepatocyte-specific JNK signaling is protective during progression of NASH Julia Piche Received Received
  SAT-141 The effects of dietary vitamin E intake on NAFLD and sex differences in serum metabolic profile Carolin Schneider Received Received
  FRI-148 Preclinical evaluation of the calpain inhibitor BLD-3051 as a therapeutic strategy for liver fibrosis Ravi Rajagopalan Received Received
  FRI-149 Experimental fibrosis alters matrix-bound vesicles cargo that do not revert after histologic recovery Toshifumi Sato Received Received
  THU-152 The therapeutic effect of Lactobacillus plantarum on metabolic phenotypes in non-alcoholic fatty liver disease mice model Dong Yun Kim Received Received
  FRI-153 Dual roles of PSMP/MSMP in the progression of hepatic fibrosis and hepatocellular carcinoma Shaoping She Received Received
  THU-153 Stool microbiota, compared to salivary microbiota, show more extensive correlations with plasma metabolites in decompensated cirrhosis in a multinational cirrhosis cohort I. Jane Cox Received Received
  FRI-154 NKT cells promote both type 1 and type 2 inflammatory responses in the non-obese diabetic inflammation and fibrosis (NIF) mouse model Sofia Mayans Received Received
  THU-155 Mitochondrial hyperactivation determines a transferable protective gut microbiota profile in metabolic-associated fatty liver disease development María Juárez-Fernández Received Received
  FRI-162 Imaging of fibrosis in metabolic associated liver disease by a radiolabeled affibody targeting PDGFRB Olivia Wegrzyniak Received Received
  FRI-163 Liver complications in greek patients with sickle cell disease: a multicenter retrospective analysis from eight thalassemia and sickle cell units across Greece Konstantinos Manganas Received Received
  THU-164 Dynamics of the gut-liver axis in rats with varying fibrosis severity Hongyan Xiang Received Received
  FRI-166 Inhibition of 11beta-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH Haeng Ran Seo Received Received
  FRI-172 The protective effect of time-caloric restriction in liver fibrosis induced by nitrosamines in rat model Christian Molina-Aguilar Received Received
  FRI-178 Multicenter external validation of FIB-6: a novel, machine-learning, simple bedside score to rule out severe liver fibrosis and cirrhosis in patients with MAFLD Gamal Shiha Received Received
  THU-178 Predictive immune biomarkers to safely discontinue nucleos(t)ide analogue treatment in HBeAg negative chronic hepatitis B (NUC-B study) Sandra Phillips Received Received
  THU-179 MAIT-cells in blood are associated with a higher risk of infection in patients with cirrhosis Hannes Hagstrm Received Received
  SAT-185 The identification and characterization of novel bile acid-derived Farnesoid X Receptor agonists Dannielle Kydd-Sinclair Received Received
  FRI-186 Performance of a p-SWE method implemented on a new ultrasound system for predicting advanced liver fibrosis Alexandru Popa Received Received
  THU-189 Multi-omics analysis of human livers reveals variation in intrahepatic inflammation across chronic hepatitis B infection phases Andre Boonstra Received Received
  THU-190 Liver cirrhosis and cirrhosis etiology impacts the circulating immune mediators of early stage hepatocellular carcinoma Andre Boonstra Received Received
  FRI-201 Telomerase-null mice display defective immune activation following the induction of liver fibrosis with S. mansoni Willian Gomes Received Received
  FRI-206 LncRNA XR_592974.2 and circRNA _2599 regulated hypoxic stress response in hepatic stellate cells by targeting the miRNA-145/JMY/P53 pathway Dan Zhou Received Received
  FRI-210 Aldafermin rebalances collagen turnover in patients with NASH and liver fibrosis in the ALPINE 2/3 study Lei Ling Received Received
  FRI-217 Metabolomic profiling of capillary dry blood samples for the differential diagnoses of hepatocellular carcinoma and liver diseases Philipp Brunnbauer Received Received
  THU-217 Reducing the risk of liver cirrhosis and hepatocellular carcinoma after treatment for smoking cessation in patients with chronic hepatitis B or C infection: a 12-year follow-up study Yuan Tsung Tseng Received Received
  THU-219 Hepatocellular carcinoma screening trends in individuals with cirrhosis in North Carolina Christine Hsu Received Received
  FRI-220 Diagnostic accuracy of non-invasive imaging modalities for the diagnosis of liver cirrhosis compared to histological assessment in a clinical setting Mira Thing Received Received
  FRI-221 Use of Fibrosis-4 (FIB-4) in liver fibrosis screening: which thresholds to choose? denis ouzan Received Received
  THU-221 Rethinking the management of chronic hepatitis B in the context of rural sub-saharan Africa: results from a social justice mixed methods study in rural Senegal (the AmBASS-PeCSen study) Marion Coste Received Received
  FRI-224 Development and validation of a hepatic vascular geometrical model for noninvasive diagnosis of clinically significant portal hypertension in cirrhosis (CHESS1802) Chengyan Wang Received Received
  THU-226 Low health literacy is associated with higher healthcare service utilisation and costs among patients with cirrhosis Elizabeth Powell Received Received
  SAT-229 Outcomes of living liver donors are worse than those of matched healthy controls: nationwide cohort study Jong Man Kim Received Received
  SAT-230 Pretransplant changes in serum protein glycosylation relate to risk of HCC recurrence after liver transplantation and provide a potential prognostic biomarker: a proof-of-concept study Xavier Verhelst Received Received
  FRI-231 Shear wave elastography is a useful and accurate tool to triage patients with acute liver failure syndromes Francesca M Trovato Received Received
  SAT-231 Liver transplantation for complications of hepatoportal sclerosis Andrew Keaveny Received Received
  THU-231 HBV screening in west african migrant community and faith-based organizations increases HBV vaccination among this high-risk population in greater Barcelona, Spain Camila A Picchio Received Received
  SAT-232 Discordance in categorization of acute-on-chronic-liver-failure in the national transplant database Brian Lee Received Received
  THU-232 Community-based HBV testing among west african migrants in greater Barcelona, Spain increases linkage to specialist care and vaccination: the HBV-COMSAVA model Camila A Picchio Received Received
  SAT-233 Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients Valentina Cossiga Received Received
  SAT-236 Formal referral networks optimise patient ion for liver transplantation Oliver Tavabie Received Received
  THU-237 Real life pooling of plasma samples for hepatitis C RNA detection as a screening strategy of hepatitis C active chronic infection Federico Garcia Garcia Received Received
  THU-238 Epidemiology of hepatocellular carcinoma in Portugal Mario Jorge Silva Received Received
  THU-242 Hepatitis C care cascade analysis among adult women in Georgia Ketevan Stvilia Received Received
  THU-244 Could a multi-target blood test make hepatocellular carcinoma surveillance programs more effective? A modelling-based virtual trial Jagpreet Chhatwal Received Received
  SAT-246 The outcome of living donor versus deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis Beshoy Elkomos Received Received
  SAT-251 Use of statins after liver transplantation is associated with improved survival: results of a nationwide study Chiara Becchetti Received Received
  THU-255 A novel hepatitis C intervention in Denmark to test and treat people who inject drugs Jeffrey Lazarus Received Received
  SAT-257 Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) specific cellular and humoral immunity in Corovavirus Disease-2019 (COVID-19) convalescence after liver transplantation - a prospective six month follow up Theresa Kirchner Received Received
  SAT-261 Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients Manuel Mendizabal Received Received
  THU-262 Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis Binu John Received Received
  SAT-262 Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time Claire Harrington Received Received
  THU-264 The protective role of dairy protein on sarcopenic obesity in middle-aged and older women: a community-based, 12-year, prospective cohort study Jun-Hyuk Lee Received Received
  SAT-266 The prognostic effect of adequate lymphadenectomy in clinically node-negative patients undergoing liver resection for intrahepatic cholangiocarcinoma Carlo Sposito Received Received
  THU-285 Measuring the alcohol related hospital burden in Ireland and the impact of Minimum Unit Pricing (MUP) Tobias Maharaj Received Received
  FRI-288 Fontan associated liver disease: A cohort review into the prevalence of portal hypertension Hannah Donnelly Received Received
  SAT-288 Liver transplant recipients have a higher incidence of lung cancer than general population Jose Ignacio Herrero Received Received
  SAT-297 Does m-RNA Vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients? Ubaldo Visco Comandini Received Received
  SAT-299 Clinical significance of three-dimensional printing of the portal venous system in patients with extrahepatic portal hypertension Binita Chaudhary Received Received
  THU-301 Hepatitis E Virus Capsid Antigen (HEV-Ag): a practical diagnostic biomarker in the HEV outbreak scenerio Simon Lytton Received Received
  FRI-302 Active case management to connect hepatitis C notifications to care and treatment in Australia (CONNECT study), a randomised controlled trial Tafireyi Marukutira Received Received
  SAT-304 Managing HBV/HDV co-infection post liver transplant - Exploring a decade of experience Almuthana Mohamed Received Received
  FRI-304 Effectiveness of a central monitoring system for the continuum of care of hepatitis C in Brazil during COVID-19 pandemic Paulo Bittencourt Received Received
  FRI-305 Retrieval of HCV patients lost to follow-up as a strategy as a strategy for hepatitis C microelimination: results of a brazilian multicentric study Paulo Bittencourt Received Received
  SAT-306 Outcome of choledochal cysts with intrahepatic involvement (type IV-A) after extrahepatic cyst excision and roux-en-Y hepaticojejunostomy in adults Utpal Anand Received Received
  FRI-310 The korean hepatitis C virus care cascade in a tertiary institution: current status and changes in testing, link to care, and treatment Jonggi Choi Received Received
  FRI-311 Macroeconomic assessment of overall and per-patient healthcare costs of Hepatitis C-infected patients in an integrated health system in the era of direct-acting antiviral therapy David Kaplan Received Received
  THU-312 A versatile small animal immunocompromised model for chronic hepatitis E Siddharth Sridhar Received Received
  SAT-319 The crucial role of PARP poly(ADP-ribose polymerase on the post-ischemic liver injury and inflammation Michitaka Ozaki Received Received
  THU-327 Therapeutic suppression of HBV transcripts promotes reappearance of the SMC5/6 complex and cccDNA silencing in vivo without affecting posttranslational modifications of cccDNA-bound histones Lena Allweiss Received Received
  FRI-337 From extensive to intensive screening, co-operations model of hepatitis C elimination in out-patients and people who inject drug population in southwest of China Qing Lin Received Received
  FRI-345 Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response - data from the german hepatitis C-registry (DHC-R) Stefan Mauss Received Received
  FRI-348 Suboptimal follow-up, high re-infection, and drug-related death, among HCV-treated people who inject drugs in Tayside, Scotland Christopher Byrne Received Received
  SAT-349 Tenofovir alafenamide for pregnant chinese women with active chronic hepatitis B: a multicenter, prospective, real-world study Qing-Lei Zeng Received Received
  FRI-350 Five-years follow-up of cured HCV patients with or without cirrhosis under real-world interferon-free therapy Robert Flisiak Received Received
  SAT-350 Suboptimal virological response to antiviral therapy in chronic hepatitis B as an independent predictor for occurrence of HCC and development of severe liver events Chau-Ting Yeh Received Received
  THU-352 Hepatitis B Delta: assesment of knowledge and practices of French non academic hepato-gastroenterologists Jean-Franois Cadranel Received Received
  SAT-355 HBV RNA levels are associated with virological response to treatment with pegylated interferon alpha in patients with chronic hepatitis D virus infection Lisa Sandmann Received Received
  SAT-356 Management of chronic hepatitis B virus infection within a large integrated health care setting: treatment patterns among kaiser permanente members in southern california, 2008 - 2019 Deborah Malden Received Received
  THU-357 The Comparison of Tenofovir Alafenamide Fumarate with Tenofovir Disoproxil Fumarate in Preventing Hepatitis B Transmission in Mothers with High Viral Load: A Retrospective Cohort Study Yunxia Zhu Received Received
  THU-360 Liver fibrosis burden determines risk of hepatocellular carcinoma among patients with hepatitis B surface antigen seroclearance Lung-Yi Mak Received Received
  THU-361 Estimating the prevalence of hepatitis delta infection among foreign-born adults with chronic hepatitis B in the United States Robert Wong Received Received
  SAT-362 Therapeutic vaccination with CLB-3000 in a mouse model of chronic hepatitis B induces anti-HBs responses associated with functional cure Aileen Rubio Received Received
  THU-364 Suboptimal glycemic control is associated with adverse clinical outcomes in patients with chronic hepatitis B and diabetes mellitus Lung-Yi Mak Received Received
  THU-365 Statin use and surface antigen loss in patients with chronic hepatitis B Shahed Iqbal Received Received
  THU-366 Patient engagement in hepatitis B clinical trials: HBV cure is a motivation for participation in all ethnically diverse patients Almuthana Mohamed Received Received
  SAT-369 Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China) - 3.5 years data update Chan Xie Received Received
  THU-371 A decision-making model for prediction of a stable disease course in chronic hepatitis B patients Imri Ofri Received Received
  SAT-374 Two-year safety and efficacy of tenofovir alafenamide in chronic hepatitis B: a HEllenic multicenter ReAl-life CLInical Study (HERACLIS-TAF) George Papatheodoridis Received Received
  THU-378 Impact of hepatitis B virus infection on liver-related death among people tested for HBV in British Columbia: results from a large longitudinal population-based cohort study Makuza Jean Damascene Received Received
  SAT-378 Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B Jihye Lim Received Received
  FRI-383 Requests for drug-drug interaction data on direct-acting antivirals and enzyme inducing anti-epileptic agents: an overview of the HEP Interaction checker database of the University of Liverpool David Burger Received Received
  FRI-389 HCV-RNA viral load fingerstick assay as a simplified strategy for screening and linkage to care of people who use drugs attending 3 french addiction centers Denis Ouzan Received Received
  FRI-390 Pangenotypic and genotype-specific antivirals in the treatment of genotype 4 infected patients with HIV coinfection Dorota Zarebska-Michaluk Received Received
  FRI-391 Long-term follow-up of HCV resistance-associated substitutions after DAA treatment failure Julia Dietz Received Received
  THU-392 Time for universal screening for hepatitis D? A study describing screening patterns, characteristics and outcomes of hepatitis D virus infection Rohit Nathani Received Received
  SAT-399 Early antiviral efficacy of tenofovir alafenamide fumarate in the initial treatment of chronic hepatitis B patients with normal ALT Xin Chi Received Received
  THU-402 Prevalence of HBV infection and receiving antiviral treatment for eligible patients in blood relatives from clustering families of HBV infection with unfavorable prognoses and cascading of care linked to treatment in West China yuan yang Received Received
  FRI-406 Effectiveness of pangenotypic retreatment of HCV infection after prior failure of pangenotypic therapies Robert Flisiak Received Received
  SAT-420 Comparison of body weight and lipid profiles following tenofovir disoproxil fumarate or entecavir switching to tenofovir alafenamide - an interim analysis Pin-Nan Cheng Received Received
  SAT-432 Low level of HBcrAg is beneficial to functional cure obtained with pegylated interferon therapy in inactive HBsAg carriers Zhenhuan Cao Received Received
  THU-438 Analyses of obeticholic acid treatment retention in UK patients based on medicine delivery data Carl Gibbons Received Received
  SAT-442 Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos(t)ide analogue: 96-week results from a prospective multinational study Eiichi Ogawa Received Received
  THU-444 Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study Marcus Maximilian Mcke Received Received
  SAT-445 Generation and functional analsis of spacer modified HBV-specific chimeric antigen receptors that harbor a Fab fragment as binding domain Zhe Xie Received Received
  THU-446 Extrahepatic autoimmune diseases in autoimmune hepatitis: effect on mortality Rasmine Birn-Rydder Received Received
  SAT-449 Tenofovir alafenamide fumarate increased lipid levels in hepatitis B virus patients Wenjuan Zhao Received Received
  THU-463 The prevalence of primary biliary cholangitis (PBC) is on the rise: a canadian population-based study Bryce Tkachuk Received Received
  THU-465 Autoimmune hepatitis diagnosed after COVID-19 vaccination. Results from the spanish registry for autoimmune and cholestatic hepatitis Ana Barreira Received Received
  THU-477 Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals Anne-Sofie Houlberg Jensen Received Received
  FRI-485 TIPS insertion leads to partial reversal of systemic inflammation in patients with decompensated liver cirrhosis Lena Stockhoff Received Received
  SAT-486 Evaluation of Interleukin-6 for stepwise diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis Simon Johannes Gairing Received Received
  SAT-488 The effect of sarcopenia on survival of patients with cirrhosis: a systematic review and meta-analysis Xinxing Tantai Received Received
  FRI-489 Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: relation to severity? Puria Nabilou Received Received
  SAT-489 Effectiveness of probiotics in the secondary prevention of hepatic encephalopathy among cirrhotic patients Muhammad Farooq Hanif Received Received
  SAT-490 Sarcopenia as a predictor of mortality and complications in cirrhosis patients - A prospective cohort study NIDHIN DEVADAS Received Received
  FRI-493 Transjugular intrahepatic portosystemic shunt versus balloon-occluded transvenous obliteration for the management of ectopic varices Ranya Selim Received Received
  THU-494 Serum metabolites on admission associate with the development of nosocomial infections in inpatients with cirrhosis Jasmohan S Bajaj Received Received
  THU-496 Renal and circulatory effects of terlipressin in patients with hepatorenal syndrome assessed by magnetic resonance imaging Puria Nabilou Received Received
  SAT-496 SBP vs. non-SBP bacterial infections at admission have comparable outcomes in a multi-center cohort of inpatients with cirrhosis Jacqueline OLeary Received Received
  THU-497 SARS-CoV-2 infection in patients with underlying chronic liver disease is associated with significantly greater risks of inpatient hospitalization, intensive care unit admission, and overall mortality Robert Wong Received Received
  SAT-497 Natural history of Hepatic Encephalopathy (HE) in a tertiary referral centre for hepatology Chiara Mangini Received Received
  SAT-498 Public knowledge and attitudes toward liver diseases and liver cancer in the brazilian population Paulo Bittencourt Received Received
  SAT-503 Risk of herpes zoster infection in patients with cirrhosis: a nationwide population-based study in Korea DONGSUB JEON Received Received
  SAT-505 Application of CT-contrast media is not associated with a higher risk for acute kidney injury in patients with decompensated liver cirrhosis Tammo Lambert Tergast Received Received
  FRI-508 Simultaneous large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: a randomized controlled trial Guohong Han Received Received
  FRI-512 Personalized preemptive TIPS treatment for patients with Child-Pugh B cirrhosis and acute variceal bleeding by applying individualized of prediction of treatment effect Guohong Han Received Received
  SAT-513 Kidney transplant alone recipients with advanced liver disease have similar outcomes to those without advanced liver disease - a single center study of 150 patients Rohit Nathani Received Received
  FRI-517 Ruling out varices needing treatment with a non-invasive score in patients with compensated HBV cirrhosis Giacomo Emanuele Maria Rizzo Received Received
  THU-521 Use of Tocilizumab in patients with stable Chronic Liver Disease and severe COVID-19 for prevention of Decompensated Cirrhosis, a Prospective, Open-label, Randomized Controlled Trial. Luis Alejandro Rosales Renteria Received Received
  THU-526 Increased platelet aggregation in decompensated cirrhosis indicates higher risk of further decompensation and liver-related mortality Alberto Zanetto Received Received
  THU-537 The regulatory protein and gene expression profile of skeletal muscle in chronic liver disease patients Sophie Allen Received Received
  SAT-538 Effect of hepatitis B virus treatment on all causes and liver-related death among patients living with HBV with cirrhosis in British Columbia in a population-based cohort study Makuza Jean Damascene Received Received
  FRI-543 Cancer-associated fibroblasts nurture LGR5 marked liver tumour-initiating cells and promote their metastasis Qiuwei Pan Received Received
  FRI-545 Identification of new dominant neoantigens in hepatocellular carcinoma based on a single plasmid system with co-expressing patients HLA and antigen Pu Chen Received Received
  FRI-546 Polypeptide N-acetylgalactosaminyltransferase 14 mediated O-glycosylation on prohibitin-2 serine 161 modulates cell growth, migration and drug susceptibility in hepatocellular carcinoma Chau-Ting Yeh Received Received
  FRI-547 Gut bacteria modulate anti-tumour immunity in patients with hepatocellular carcinoma Antonio Riva Received Received
  FRI-549 Role of autophagy-mediated neuropilin-1 degradation on lenvatinib efficacy in human hepatocarcinoma Paula Fernández-Palanca Received Received
  THU-550 miRNA associated with systemic inflammation may have prognostic utility in predicting decompensation in patients with chronic liver disease Oliver Tavabie Received Received
  FRI-552 Hippo inactivation drives BMI1-associated proliferative hepatocarcinogenesis in chronic hepatitis B virus infection Ruth Broering Received Received
  FRI-554 Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis Leticia Colyn Received Received
  SAT-556 Validation of a glycomics-based test associated with risk of HCC development in cirrhosis Xavier Verhelst Received Received
  SAT-559 NanoView EV Chip-based profiling in liver cancer differentiation - HCC from intrahepatic CCA - small EVs vs large EVs Bingduo Wang Received Received
  SAT-562 Diagnostic accuracy of protein-induced by vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) among caucasian cirrhotic patients with or without diagnostic serum a-fetoprotein (AFP) levels antonia syriha Received Received
  FRI-563 High plasma level of osteopontin, a potential biomarker in hepatocellular carcinoma, is associated with weakened anti-tumour immunity Tengfei Si Received Received
  SAT-565 On treatment alpha-fetoprotein reductions predict immunotherapy efficiency in patients with hepatocellular carcinoma Bernhard Scheiner Received Received
  SAT-567 Non-alcoholic fatty liver disease and increased risk of incident primary liver tumours: a meta-analysis of observational cohort studies Andrea Dalbeni Received Received
  SAT-569 Machine learning algorithm based on dual screening for hepatocellular carcinoma using circulating cell-free DNA and cfDHCC scoring system HYUK SOO EUN Received Received
  THU-570 Textbook outcome after major hepatectomy for perihilar cholangiocarcinoma - definitions and influencing factors Christian Benzing Received Received
  SAT-576 A novel hierarchical fusion strategy of deep learning networks to detect hepatocellular carcinoma from dynamic computed tomography images I-Cheng Lee Received Received
  THU-577 Incidence of hepatocellular carcinoma reduced in chronic hepatitis B patients treated with entercavir plus Biejia-Ruangan: extended follow-up of a multicenter, randomised, double-blinded, placebo-controlled trial Dong Ji Received Received
  FRI-578 ACSL4-dependent ferroptosis promotes HCC progression Julia Piche Received Received
  THU-582 Implementation of a new prognostic scoring system after major hepatectomy in curative intent for perihilar cholangiocarcinoma Christian Benzing Received Received
  SAT-585 Multiparametric ultrasound approach using a tree based decision classifier for the inconclusive focal liver lesions evaluated by contrast enhanced ultrasound Tudor-Voicu Mpga Received Received
  FRI-586 Different immunological microenvironment in patients with different cirrhosis etiology and hepatocellular carcinoma Andrea Dalbeni Received Received
  SAT-592 Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different BCLC stages undergoing curative hepatectomy Grace Wong Received Received
  THU-594 The influence of fasting on tumor-targeted drug delivery Svea Becker Received Received
  SAT-596 Germline Genetic Risk Factors for the Development of Hepatocellular Carcinoma among Patients with Cirrhosis: A Genome-Wide Association Study of U.S. Veterans David Kaplan Received Received
  FRI-999 Test 1 Art Vandeley Received Received

Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 22/06/2022 TO 22/06/2023
Featured Poster
Vote poster
Poster Discussion
                   DOI: 10.3252/ 

Logo Draft
Logo Cert